Anjana Ranganathan in Bensalem, Pennsylvania

Home Pennsylvania Bensalem

Anjana Ranganathan has Medical Oncology as her primary medical specialty. Their primary office is: 1311 Bristol Pike in Bensalem, Pennsylvania. There is an additional office location, for a total of two, for Anjana Ranganathan that can be viewed further down.

They're a part of the: Alliance Cancer Specialists medical group which has around 54 members. You can call their office at 215-645-1740 to schedule an appointment. They also accept the Medicare-approved amount as payment in full. They attended University Of Pittsburgh School Of Medicine and graduated in 2006 (around 18 years of experience). They are not listed as doing telehealth appointments, but this may have changed. It can't hurt to call and check. If anything it may encourage them to make them available if they are not currently.

Anjana Ranganathan Office Phone and Directions

Anjana Ranganathan
Alliance Cancer Specialists
1311 Bristol Pike
Bensalem, Pennsylvania 19020
215-645-1740

Patient Ratings
Please rate your experience with Anjana Ranganathan below to help others make a more informed decision. Thanks!

Current Rating: Loading...

Phone: 215-645-1740

Enter a starting address:

Healthcare Info for Anjana Ranganathan

Additional Medical Specialties Include:
HOSPICE/PALLIATIVE CARE, INTERNAL MEDICINE

Medical School: University Of Pittsburgh School Of Medicine
Graduation Year: 2006
The Primary Medical Specialty for Anjana Ranganathan is listed as: Medical Oncology
Approximate Years of Experience: 18
PAC (PECOS ID)#: 2668528324
NPI #: 1437324845
NPI Created On: 04/25/2008
NPI Last Updated Listed as: 08/07/2014
Primary Taxonomy Code: 207RX0202X
License Number:
MD442076
Listed Gender: Female

Insurance, Services, Charges

Forms of insurance accepted by include, but are not limited to:

AmeriHealth New Jersey
Blue Cross Blue Shield
Highmark Health Insurance Company
AmeriHealth HMO, Inc.
Highmark Inc.
Pennsylvania Health & Wellness, Inc.
Medicare

They are listed as accepting new patients.

Languages spoken by staff include: English, Spanish.

Services and Procedures include:

Insertion of needle into vein for collection of blood sample
Complete blood cell count (red cells, white blood cell, platelets), automated test
Infusion into a vein for therapy, prevention, or diagnosis up to 1 hour
Infusion into a vein for therapy prevention or diagnosis additional sequential infusion up to 1 hour
Injection beneath the skin or into muscle for therapy, diagnosis, or prevention
Injection of different drug or substance into a vein for therapy, diagnosis, or prevention
Infusion of chemotherapy into a vein up to 1 hour
Infusion of chemotherapy into a vein
Infusion of different chemotherapy drug or substance into a vein up to 1 hour
New patient office or other outpatient visit, typically 45 minutes
New patient office or other outpatient visit, typically 60 minutes
Established patient office or other outpatient visit, typically 15 minutes
Established patient office or other outpatient, visit typically 25 minutes
Established patient office or other outpatient, visit typically 40 minutes
Initial hospital inpatient care, typically 50 minutes per day
Subsequent hospital inpatient care, typically 25 minutes per day
Injection, dexamethasone sodium phosphate, 1 mg
Injection, diphenhydramine hcl, up to 50 mg
Injection, ferric carboxymaltose, 1 mg
Injection, fosaprepitant, 1 mg

They took part in Medicare's Electronic Health Record Incentive Program which was designed to help move people over to electronic records and improve the systems that were already in place.
They took part in the Medicare Physician Quality Reporting System (PQRS).

Open Payments Data. This can include items to test (Durable Medical Equipment (DME)), Biological, Drug Samples, etc. This data must be reported to CMS.

Payments Total: $22

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 781017597

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: ONCOLOGY

Name of Drug #1: IMBRUVICA

Open Associated Drug #1: 57962-420-28

Payments Total: $100

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 781017599

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: ONCOLOGY

Name of Drug #1: IMBRUVICA

Open Associated Drug #1: 57962-420-28

Payments Total: $14

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 795773171

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: ONCOLOGY

Name of Drug #1: VENCLEXTA

Open Associated Drug #1: 0074-0576-22

Payments Total: $16

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 818948021

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Oncology

Name of Drug #1: VERZENIO

Open Associated Drug #1: 0002-6216-54

Drug or Biological: Drug

Product Category #2: Oncology

Name Of Drug #2:: RETEVMO

Associated Drug #2: 0002-2980-60

Payments Total: $16

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 802549633

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: ONCOLOGY

Name of Drug #1: ZEJULA

Open Associated Drug #1: 69656-103-90

Payments Total: $31

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 832182833

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Oncology

Name of Drug #1: TUKYSA

Open Associated Drug #1: 51144-001-60

Payments Total: $19

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 832182849

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Oncology

Name of Drug #1: TUKYSA

Open Associated Drug #1: 51144-001-60

Payments Total: $16

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 832182853

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: Oncology

Name of Drug #1: PADCEV

Open Associated Drug #1: 51144-030-01

Payments Total: $12

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 832182857

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: Oncology

Name of Drug #1: PADCEV

Open Associated Drug #1: 51144-030-01

Payments Total: $24

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 813187717

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: ONCOLOGY

Name of Drug #1: KISQALI

Open Associated Drug #1: 0078-0860-01

Drug or Biological: Drug

Product Category #2: ONCOLOGY

Name Of Drug #2:: FEMARA

Associated Drug #2: 0078-0249-15

Additional Office Locations

1. Alliance Cancer Specialists
1203 Langhorne Newtown Rd
Langhorne, PA 19047
Suite 135
Group Members: 54

Phone: 215-645-1740

Enter a starting address:

Providers in Alliance Cancer Specialists

1.Bineetha Abraham

1000 Floral Vale Blvd
Yardley Pa 19067-5583
Alliance Cancer Specialists
Nurse Practitioner

2.Bineetha Abraham

2630 Holme Ave
Philadelphia Pa 19152-3004
Alliance Cancer Specialists
Nurse Practitioner

3.Sramila Aithal

1311 Bristol Pike
Bensalem Pa 19020-6415
Alliance Cancer Specialists
Hematology/oncology

4.Mitchell Alden

1203 Langhorne Newtown Rd
Langhorne Pa 19047-1212
Alliance Cancer Specialists
Hematology/oncology

5.Zonera Ali Md

1203 Langhorne Newtown Rd
Langhorne Pa 19047-1212
Alliance Cancer Specialists
Hematology/oncology

6.Zonera Ali Md

100 E Lancaster Ave
Wynnewood Pa 19096-3450
Alliance Cancer Specialists
Hematology/oncology

View all 54 members of Alliance Cancer Specialists medical group